Navigation Links
SoluLinK Introduces ChromaLink(TM) Biotin Labeling Kit to Biotinylate and Measure With One Reagent

SAN DIEGO, Jan. 29 /PRNewswire/ --- SoluLinK, Inc., a leader in biomolecular conjugation products and kits, announced the introduction of their newest product, the ChromaLink Biotin Labeling Kit, a biotinylation reagent with a built-in measurement signature that comes as a complete, easy-to-use kit. ChromaLink is an innovative biotinylation reagent that includes a direct, non-destructive, UV measurement of incorporated biotin within a single reagent.

-- Complete Kit: All necessary reagents included as well as a foolproof

protocol provided on a flash drive

-- Built-in Quantitative Signal: Incorporated biotin quantified by simple

absorbance -- no HABA or fluoro-reporter assay needed -- only a simple

UV scan needed to measure

-- Versatile: Labels 25 micrograms to 1 mg of antibody

-- Safe and Economical: Water-soluble, mild on antibodies -- no DMF needed

"ChromaLink is the first in a line of our products designed to address existing market needs with effective technology, supplied in a complete, easy to use format. This line of products will provide complete assay solutions for specific market applications. SoluLinK's continuous and ongoing innovation of conjugation chemistry has provided significant contributions to our customers' and collaborators' ability to build greater value into their products. SoluLinK has established a strong leadership position in conjugation and continues to actively build, maintain, and manage our products and patented IP," observed Steve DeGraw, President of SoluLinK.

About SoluLinK

SoluLinK is a leader in the development of conjugation reagents, kits, and OEM services for the life sciences, diagnostic, and pharmaceutical communities. SoluLinK develops, manufactures, and markets bioconjugation products and services. Their proprietary bioconjugation linking chemistry is used to link proteins, oligonucleotides, peptides, and antibodies to each other or to a wide range of surfaces. Rapidly growing applications for SoluLinK's products include the conjugation of biomolecules for research assay, diagnostic, and pharmaceutical products. SoluLinK's proprietary ChromaLink Biotin Labeling Kit for biotinylation is one example. It is also the first product introduced from the pipeline of a new, easy to use kits that will help to enhance assay performance and measurement for customers in a broad range of large markets. SoluLinK markets these products both directly and through distributors and licensing partners world-wide. SoluLinK is a privately held company located in San Diego, California. For more information, please visit

SOURCE SoluLinK, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Biomatrica Introduces SampleWare(R) Version 3.0 Software for Laboratory Sample Management
2. Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye
3. Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use
4. Microfabrica Introduces Set of Miniature Building Blocks for Minimally-Invasive Medical Devices
5. Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction
6. Finesse Introduces TruBio(TM) IOQ
7. Nikon Instruments Introduces NIS-Elements Software for Eclipse Ti-E Live-Cell Applications
8. EDDA Technology Introduces Universal Enterprise Solution - Enabling 2D/3D/4D Advanced Clinical Applications on Existing PACS Workstations
9. H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products
10. WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
11. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
Post Your Comments:
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... 2015 Cepheid (NASDAQ: CPHD ) today ... following conference, and invited investors to participate via webcast. ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ... New York, NY      Tuesday, December 1, 2015 ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology:
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
Breaking Biology News(10 mins):